Calcitonin gene-related peptide (CGRP) concentrations outside migraine attacks in peripheral blood as a potential biomarker for chronic migraine
DOI:
https://doi.org/10.48208/HeadacheMed.2023.18Palavras-chave:
Migraine disorders, Chronic migraine disorders, Biomarkers, Calcitonin gene-related peptide, Neuropeptides, Blood specimen collection, Peripheral blood, Interictal period, Disease progressionResumo
Abstract
Introduction
Chronic migraine is a debilitating condition that affects a significant portion of the population. Accurate diagnosis and treatment of chronic migraine remain a challenge due to the lack of objective biomarkers. Calcitonin gene-related peptide (CGRP) is a neuropeptide involved in the pathophysiology of migraine and has been proposed as a potential biomarker for migraine.
Methods
We measured CGRP levels in peripheral blood samples collected from 142 participants with chronic or episodic migraine and 24 healthy controls during ictal periods, i.e., outside migraine attacks. We compared CGRP levels between the three groups and assessed the correlation between CGRP levels and clinical features of chronic migraine.
Conclusion
Our study provides evidence that CGRP levels in peripheral blood during ictal periods may serve as a potential biomarker for chronic migraine. Further studies are needed to validate these findings and to explore the clinical utility of CGRP as a biomarker for chronic migraine.
Downloads
Referências
Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L and Lipton RB. Global prevalence of chronic migraine: A systematic review. Cephalalgia 2009; 30(5): 599-609 Doi:10.1111/j.1468-2982.2009.01941.x DOI: https://doi.org/10.1111/j.1468-2982.2009.01941.x
Kulkarni GB, Rao GN, Gururaj G, Stovner LJ and Steiner TJ. Headache disorders and public ill-health in India: prevalence estimates in Karnataka State. The Journal of Headache and Pain 2015; 16(1): Doi:10.1186/s10194-015-0549-x DOI: https://doi.org/10.1186/s10194-015-0549-x
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38(1): 1-211 Doi:10.1177/0333102417738202 DOI: https://doi.org/10.1177/0333102417738202
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC and Lipton RB. Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study. Headache: The Journal of Head and Face Pain 2012; 52(10): 1456-1470 Doi:10.1111/j.1526-4610.2012.02223.x DOI: https://doi.org/10.1111/j.1526-4610.2012.02223.x
Garza I and Schwedt T. Diagnosis and Management of Chronic Daily Headache. Seminars in Neurology 2010; 30(02): 154-166 Doi:10.1055/s-0030-1249224 DOI: https://doi.org/10.1055/s-0030-1249224
Durham PL. Calcitonin Gene-Related Peptide (CGRP) and Migraine. Headache: The Journal of Head and Face Pain 2006; 46(s1): S3-S8 Doi:10.1111/j.1526-4610.2006.00483.x DOI: https://doi.org/10.1111/j.1526-4610.2006.00483.x
Goadsby PJ, Edvinsson L and Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Annals of Neurology 1988; 23(2): 193-196 Doi:10.1002/ana.410230214 DOI: https://doi.org/10.1002/ana.410230214
Cernuda-Morollón E, Martínez-Camblor P, Alvarez R, Larrosa D, Ramón C and Pascual J. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine. Cephalalgia 2014; 35(4): 310-316 Doi:10.1177/0333102414535111 DOI: https://doi.org/10.1177/0333102414535111
Herekar AA, Ahmad A, Uqaili UL, Ahmed B, Effendi J, Alvi SZ, . . . Steiner TJ. Primary headache disorders in the adult general population of Pakistan – a cross sectional nationwide prevalence survey. The Journal of Headache and Pain 2017; 18(1): Doi:10.1186/s10194-017-0734-1 DOI: https://doi.org/10.1186/s10194-017-0734-1
Alzoubi KH, Mhaidat N, azzam SA, Khader Y, Salem S, Issaifan H and Haddadin R. Prevalence of migraine and tension-type headache among adults in Jordan. The Journal of Headache and Pain 2009; 10(4): 265-270 Doi:10.1007/s10194-009-0122-6 DOI: https://doi.org/10.1007/s10194-009-0122-6
Hansen JM, Hauge AW, Olesen J and Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 2010; 30(10): 1179-1186 Doi:10.1177/0333102410368444 DOI: https://doi.org/10.1177/0333102410368444
Fusayasu E, Kowa H, Takeshima T, Nakaso K and Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 2007; 128(3): 209-214 Doi:10.1016/j.pain.2006.09.017 DOI: https://doi.org/10.1016/j.pain.2006.09.017
Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV and Olesen J. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides 2014; 48(2): 53-64 Doi:10.1016/j.npep.2014.01.004 DOI: https://doi.org/10.1016/j.npep.2014.01.004
Asghar MS, Hansen AE, Amin FM, van der Geest RJ, Koning Pvd, Larsson HBW, . . . Ashina M. Evidence for a vascular factor in migraine. Annals of Neurology 2011; 69(4): 635-645 Doi:10.1002/ana.22292 DOI: https://doi.org/10.1002/ana.22292
Cernuda-Morollon E, Larrosa D, Ramon C, Vega J, Martinez-Camblor P and Pascual J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 2013; 81(14): 1191-1196 Doi:10.1212/WNL.0b013e3182a6cb72 DOI: https://doi.org/10.1212/WNL.0b013e3182a6cb72
Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S and Olesen J. No increase of calcitonin gene-related peptide in jugular blood during migraine. Annals of Neurology 2005; 58(4): 561-568 Doi:10.1002/ana.20605 DOI: https://doi.org/10.1002/ana.20605
Woldeamanuel YW and Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017; 372(307-315 Doi:10.1016/j.jns.2016.11.071 DOI: https://doi.org/10.1016/j.jns.2016.11.071
Wang SJ, Fuh JL, Young YH, Lu SR and Shia BC. Prevalence of Migraine in Taipei, Taiwan: A Population-Based Survey. Cephalalgia 2016; 20(6): 566-572 Doi:10.1046/j.1468-2982.2000.00085.x DOI: https://doi.org/10.1046/j.1468-2982.2000.00085.x
Takeshima T, Ishizaki K, Fukuhara Y, Ijiri T, Kusumi M, Wakutani Y, . . . Nakashima K. Population-Based Door-to-Door Survey of Migraine in Japan: The Daisen Study. Headache: The Journal of Head and Face Pain 2004; 44(1): 8-19 Doi:10.1111/j.1526-4610.2004.04004.x DOI: https://doi.org/10.1111/j.1526-4610.2004.04004.x
Cho S, Cho S-J, Lee MJ, Park JW, Chu MK, Moon H-S, . . . Kim B-K. Clinical characteristics of pre-attack symptoms in cluster headache: A large series of Korean patients. Cephalalgia 2020; 41(2): 227-236 Doi:10.1177/0333102420966983 DOI: https://doi.org/10.1177/0333102420966983
Amara SG, Jonas V, Rosenfeld MG, Ong ES and Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982; 298(5871): 240-244 Doi:10.1038/298240a0 DOI: https://doi.org/10.1038/298240a0
Mulderry PK, Ghatki MA, Spokks RA, Jonhs PM, Pierson AM, Hamid QA, . . . Bloom SR. Differential expression of α-CGRP and β-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 1988; 25(1): 195-205 Doi:10.1016/0306-4522(88)90018-8 DOI: https://doi.org/10.1016/0306-4522(88)90018-8
Ho TW, Edvinsson L and Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nature Reviews Neurology 2010; 6(10): 573-582 Doi:10.1038/nrneurol.2010.127 DOI: https://doi.org/10.1038/nrneurol.2010.127
Moore EL and Salvatore CA. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. British Journal of Pharmacology 2012; 166(1): 66-78 Doi:10.1111/j.1476-5381.2011.01633.x DOI: https://doi.org/10.1111/j.1476-5381.2011.01633.x
Van Rossum D, Hanisch U-K and Quirion R. Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors. Neuroscience & Biobehavioral Reviews 1997; 21(5): 649-678 Doi:10.1016/s0149-7634(96)00023-1 DOI: https://doi.org/10.1016/S0149-7634(96)00023-1
Unger JW and Lange W. Immunohistochemical mapping of neurophysins and calcitonin gene-related peptide in the human brainstem and cervical spinal cord. Journal of Chemical Neuroanatomy 1991; 4(4): 299-309 Doi:10.1016/0891-0618(91)90020-d DOI: https://doi.org/10.1016/0891-0618(91)90020-D
Goadsby PJ, Edvinsson L and Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Annals of Neurology 1990; 28(2): 183-187 Doi:10.1002/ana.410280213 DOI: https://doi.org/10.1002/ana.410280213
Messlinger K, Lennerz JK, Eberhardt M and Fischer MJM. CGRP and NO in the Trigeminal System: Mechanisms and Role in Headache Generation. Headache: The Journal of Head and Face Pain 2012; 52(9): 1411-1427 Doi:10.1111/j.1526-4610.2012.02212.x DOI: https://doi.org/10.1111/j.1526-4610.2012.02212.x
Giniatullin R, Nistri A and Fabbretti E. Molecular Mechanisms of Sensitization of Pain-transducing P2X3 Receptors by the Migraine Mediators CGRP and NGF. Molecular Neurobiology 2008; 37(1): 83-90 Doi:10.1007/s12035-008-8020-5 DOI: https://doi.org/10.1007/s12035-008-8020-5
Olesen J, Burstein R, Ashina M and Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. The Lancet Neurology 2009; 8(7): 679-690 Doi:10.1016/s1474-4422(09)70090-0 DOI: https://doi.org/10.1016/S1474-4422(09)70090-0
Edvinsson L and Uddman R. Neurobiology in primary headaches. Brain Research Reviews 2005; 48(3): 438-456 Doi:10.1016/j.brainresrev.2004.09.007 DOI: https://doi.org/10.1016/j.brainresrev.2004.09.007
Strassman AM, Raymond SA and Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996; 384(6609): 560-564 Doi:10.1038/384560a0 DOI: https://doi.org/10.1038/384560a0
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 Showkat hassan Bhat, RAVOUF ASIMI, zaffar amin shah, ADNAN FIRDOUS RAINA (Author)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
